[The stream is slated to start at 10 a.m. ET. Please refresh the page if you do not see a player above at that time.] Drug company executives plan to tell the House Energy and Commerce Committee on Tuesday they can make a safe and effective Covid-19 vaccine in record time, according to written testimony…
A box of Dexamethasone tablets. Matthew Horwood/Getty Images Pharmaceutical giant Aspen Pharmacare has said that it is ready to scale up production of a generic anti-inflammatory drug that could help save the lives of critically ill coronavirus patients.A mass treatment trial led by Oxford University this week found that a low-dose steroid named dexamethasone could…
A GSK lab in London.Oli Scarff | Getty ImagesThere were several major developments over the last week with the medical community marking progress in all three critical areas: testing, treatments and vaccines.Experts have welcomed positive data on potential treatments and progress on testing, but warn that vaccine timelines look ambitious and argue more thought is…
First results of human trials expected in June By Mike Moffitt, SFGATE Published 3:12 pm PDT, Thursday, April 30, 2020 This screen grab taken from video issued by Britain's Oxford University shows microbiologist Elisa Granato being injected as part of the first human trials in the UK for a potential coronavirus vaccine on April 23, 2020.…
April 22, 2020 | 3:37pm | Updated April 22, 2020 | 4:26pm Martin Shkreli put a ring on it. The 37-year-old disgraced Pharma Bro has a fiancée, his attorneys said Wednesday in a compassionate release request to spring Shkreli from a minimum-security prison in Pennsylvania. Shkreli is asking to spend the remainder of his seven-year…
Céline Gounder, KFF Health News’ editor-at-large for public health, discussed a new weight loss pill approved by the FDA on CBS News’ CBS Mornings on April 2. Click here to watch Gounder on CBS Mornings. KFF Health News Southern correspondent Sam Whitehead discussed high Affordable Care Act premiums on WUGA’s The Georgia Health Report on
States are paying contractors such as Deloitte, Accenture, and Optum millions of dollars to help them comply with the One Big Beautiful Bill Act — a law that will strip safety-net health and food benefits from millions. State governments rely on such companies to design and operate computer systems that assess whether low-income people qualify
You don't have permission to access "http://www.medpagetoday.com/hematologyoncology/prostatecancer/120620" on this server. Reference #18.2c153b17.1775163741.18014a6 https://errors.edgesuite.net/18.2c153b17.1775163741.18014a6